Our role is essentially to oversee the food supply and to use our regulatory and non-regulatory levers to achieve public health outcomes, and in that regard we've mentioned the replacement options. Some of these replacement options are required to undergo a pre-market review. We have treated the oilseeds and the novel crops that are identified as suitable replacement options as priorities for our pre-market review, and Health Canada has approved a number of them. As recently as March 2008 we approved a new variety of soybean that would result in a suitable replacement option that would essentially mitigate the need to resort to trans fats.
On May 6th, 2010. See this statement in context.